On this week’s Opinionated Science, the team take a look at the growing potential of psychedelic medicine.Hundreds of new clinical trials, exciting new synthetic psychedelics and a universal acceptance that current mental health treatments are not meeting patients’ needs have pushed the mind-altering potential of psychedelics into the medical mainstream.In this episode, Technology Networks Senior Science Writer Ruairi J Mackenzie takes a deep dive into four leading psychedelic compounds: psilocybin, MDMA, ketamine and DMT.Read more from this podcast:Why Does Ketamine Fight Depression? Finding Answers at BNA 2019Mirror’s Image: Could a Simple Flip Produce a More Effective Ketamine-Based Antidepressant?The Neuroscience of Psychedelic Drugs: Your Brain on Psilocybin With Frederick Streeter Barrett
Podden och tillhörande omslagsbild på den här sidan tillhör technologynetworks. Innehållet i podden är skapat av technologynetworks och inte av, eller tillsammans med, Poddtoppen.
